SGRY (Surgery Partners) Piotroski F-Score: 4 (As of Aug. 07, 2026) — 20% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SGRY Surgery Partners Inc SGRY
66 GF Score
Price $15.28
GF Value $26.81
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Surgery Partners Piotroski F-Score?

Surgery Partners SGRY +2.38% 66 Piotroski F-Score is 4 as of Aug. 07, 2026, which is 20% below its 10-year median of 5.00. GuruFocus rates SGRY with a GF Score™ of 66/100 and a GF Value™ of $26.81 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 646 Healthcare Providers & Services companies, Surgery Partners ranks worse than 66.72% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Surgery Partners has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Surgery Partners's Piotroski F-Score or its related term are showing as below:

SGRY' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 5   Max: 7
Current: 4

During the past 13 years, the highest Piotroski F-Score of Surgery Partners was 7. The lowest was 2. And the median was 5.

Surgery Partners  (NAS:SGRY) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Surgery Partners Piotroski F-Score Related Terms


Surgery Partners Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Surgery Partners's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Surgery Partners Piotroski F-Score Chart

Surgery Partners Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.00 7.00 5.00 5.00 4.00

Surgery Partners Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.00 3.00 4.00 4.00 4.00

SGRY vs AVAH, ASTH, ADUS: Piotroski F-Score Comparison

For the Medical Care Facilities subindustry, Surgery Partners's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Surgery Partners Piotroski F-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Surgery Partners's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Surgery Partners's Piotroski F-Score falls into.


SGRY
66GF Score
Surgery Partners Inc SGRY
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was -2.5 + -22.7 + -15 + -35.9 = $-76 Mil.
Cash Flow from Operations was 81.3 + 83.6 + 103.4 + 11.7 = $280 Mil.
Revenue was 826.2 + 821.5 + 885 + 810.9 = $3,344 Mil.
Gross Profit was 195.6 + 195.3 + 212.2 + 160.2 = $763 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(7949.2 + 7954.8 + 7946.6 + 8119.7 + 8042.1) / 5 = $8002.48 Mil.
Total Assets at the begining of this year (Mar25) was $7,949 Mil.
Long-Term Debt & Capital Lease Obligation was $3,885 Mil.
Total Current Assets was $1,083 Mil.
Total Current Liabilities was $582 Mil.
Net Income was -15.5 + -31.7 + -108.5 + -37.7 = $-193 Mil.

Revenue was 762.1 + 770.4 + 864.4 + 776 = $3,173 Mil.
Gross Profit was 179.2 + 177.5 + 233.6 + 161.9 = $752 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(6975.6 + 7488.6 + 7534.4 + 7890 + 7949.2) / 5 = $7567.56 Mil.
Total Assets at the begining of last year (Mar24) was $6,976 Mil.
Long-Term Debt & Capital Lease Obligation was $3,720 Mil.
Total Current Assets was $1,075 Mil.
Total Current Liabilities was $569 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Surgery Partners's current Net Income (TTM) was -76. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Surgery Partners's current Cash Flow from Operations (TTM) was 280. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=-76.1/7949.2
=-0.00957329

ROA (Last Year)=Net Income/Total Assets (Mar24)
=-193.4/6975.6
=-0.02772521

Surgery Partners's return on assets of this year was -0.00957329. Surgery Partners's return on assets of last year was -0.02772521. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Surgery Partners's current Net Income (TTM) was -76. Surgery Partners's current Cash Flow from Operations (TTM) was 280. ==> 280 > -76 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=3885.4/8002.48
=0.48552449

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=3719.8/7567.56
=0.49154549

Surgery Partners's gearing of this year was 0.48552449. Surgery Partners's gearing of last year was 0.49154549. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=1082.5/581.7
=1.86092488

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=1074.6/569.4
=1.88724974

Surgery Partners's current ratio of this year was 1.86092488. Surgery Partners's current ratio of last year was 1.88724974. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Surgery Partners's number of shares in issue this year was 128.367. Surgery Partners's number of shares in issue last year was 126.602. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=763.3/3343.6
=0.22828688

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=752.2/3172.9
=0.23707019

Surgery Partners's gross margin of this year was 0.22828688. Surgery Partners's gross margin of last year was 0.23707019. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=3343.6/7949.2
=0.42062094

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=3172.9/6975.6
=0.45485693

Surgery Partners's asset turnover of this year was 0.42062094. Surgery Partners's asset turnover of last year was 0.45485693. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+1+1+1+1+0+0+0+0
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Surgery Partners has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 4 mean?
Surgery Partners (SGRY) has a Piotroski F-Score of 4 as of Aug. 07, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Surgery Partners and its competitors. This is 20% below median its historical median of 5.00. Over the past decade, Surgery Partners' Piotroski F-Score has ranged from 2.00 to 7.00. According to the industry distribution chart, Surgery Partners ranks #431 out of 646 companies in the Healthcare Providers & Services industry, placing it in the top 66.7%.
Is Surgery Partners' Piotroski F-Score too high?
Surgery Partners' current Piotroski F-Score of 4 is 20% below median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 7.00. The Healthcare Providers & Services industry median Piotroski F-Score is 5.00. Surgery Partners' value of 4 is 20% below this industry median. Based on the distribution chart, Surgery Partners ranks #431 out of 646 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Surgery Partners has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Surgery Partners' Piotroski F-Score compare to AVAH and ASTH?
According to the Healthcare Providers & Services industry distribution chart, Surgery Partners ranks #431 out of 646 companies for Piotroski F-Score. This places Surgery Partners in the lower half of its industry. The industry median Piotroski F-Score is 5.00. Surgery Partners' value of 4 is 20% below this benchmark. Historically, Surgery Partners' own Piotroski F-Score has ranged from 2.00 to 7.00 over the past decade. While the company's 10-year median is 5.00 vs. the industry median of 5.00, Surgery Partners has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Healthcare Providers & Services company?
The median Piotroski F-Score among Healthcare Providers & Services companies is 5.00, based on 646 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Surgery Partners's current Piotroski F-Score of 4 is 20% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Surgery Partners and its competitors. For the Healthcare Providers & Services industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Surgery Partners's current Piotroski F-Score is 4, which is 20% below median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surgery Partners stock overvalued right now?
Based on GuruFocus' analysis, Surgery Partners (SGRY) is currently considered Possible Value Trap. The stock's GF Value™ is $26.81, compared to a current price of $15.28 — trading 43% below its estimated fair value. The current Piotroski F-Score is 4, which is 20% below median its 10-year median of 5.00 and 20% below the Healthcare Providers & Services industry median of 5.00. Surgery Partners' overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Surgery Partners (SGRY), the current Piotroski F-Score is 4 as of Aug. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Surgery Partners (SGRY) Overvalued in 2026?

Based on GuruFocus' analysis, Surgery Partners stock appears to be undervalued. The current stock price of $15.28 is trading 43% below its estimated GF Value™ of $26.81. GuruFocus considers Surgery Partners to be Possible Value Trap.

Key valuation signals for SGRY:

  • Piotroski F-Score: 4 (20% below median its 10-year median of 5.00)
  • GF Value™: $26.81 vs. price of $15.28 (43% below fair value)
  • GF Score™: 66/100 with 4 warning signs
  • Industry Position: 20% below the Healthcare Providers & Services median (#431 of 646)

No single metric tells the full story. See the SGRY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Surgery Partners Business Description

Other Exchanges 1SP:Germany
Address 340 Seven Springs Way, Suite 600, Brentwood, TN, USA, 37027
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities, which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earn revenues from contracts with patients in which the performance obligations are to provide health care services.
66GF Score

Get the complete analysis for SGRY

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$15.28
Price
$26.81
GF Value